Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results

Liselotte M. S. Boevé; Paul C. M. S. Verhagen; André N. Vis

doi:10.1016/j.eururo.2018.11.007

Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results

Liselotte M. S. Boevé
, Paul C. M. S. Verhagen
, André N. Vis

Onze Lieve Vrouwe Gasthuis
Erasmus University Rotterdam

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	e71-e72
Journal	European urology
Volume	75
Issue number	3
DOIs	https://doi.org/10.1016/j.eururo.2018.11.007
Publication status	Published - 1 Mar 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.eururo.2018.11.007

Cite this

Boevé, L. M. S., Verhagen, P. C. M. S., & Vis, A. N. (2019). Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results. European urology, 75(3), e71-e72. https://doi.org/10.1016/j.eururo.2018.11.007

Boevé, Liselotte M. S. ; Verhagen, Paul C. M. S. ; Vis, André N. / Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results. In: European urology. 2019 ; Vol. 75, No. 3. pp. e71-e72.

@article{6bc5fe5457b143eda81f46a0149cd67e,

title = "Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boev{\'e} Maarten C.C.M. Hulshof, Andr{\'e} N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results",

author = "Boev{\'e}, \{Liselotte M. S.\} and Verhagen, \{Paul C. M. S.\} and Vis, \{Andr{\'e} N.\}",

year = "2019",

month = mar,

day = "1",

doi = "10.1016/j.eururo.2018.11.007",

language = "English",

volume = "75",

pages = "e71--e72",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "3",

}

Boevé, LMS, Verhagen, PCMS & Vis, AN 2019, 'Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results', European urology, vol. 75, no. 3, pp. e71-e72. https://doi.org/10.1016/j.eururo.2018.11.007

Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results. / Boevé, Liselotte M. S.; Verhagen, Paul C. M. S.; Vis, André N.
In: European urology, Vol. 75, No. 3, 01.03.2019, p. e71-e72.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results

AU - Boevé, Liselotte M. S.

AU - Verhagen, Paul C. M. S.

AU - Vis, André N.

PY - 2019/3/1

Y1 - 2019/3/1

UR - https://www.scopus.com/pages/publications/85060699938

U2 - 10.1016/j.eururo.2018.11.007

DO - 10.1016/j.eururo.2018.11.007

M3 - Letter

C2 - 30471883

SN - 0302-2838

VL - 75

SP - e71-e72

JO - European urology

JF - European urology

IS - 3

ER -

Boevé LMS, Verhagen PCMS, Vis AN. Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results. European urology. 2019 Mar 1;75(3):e71-e72. doi: 10.1016/j.eururo.2018.11.007

UN SDGs

Access to Document

Other files and links

Cite this